RecruitingEarly Phase 1NCT06769191

Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD

Studying Immuno-osseous dysplasia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Zhejiang University
Principal Investigator: He Huang, MD
Zhejiang University
Intervention: CD7 CAR-T cells injection(biological)
Enrollment: 20 enrolled
Eligibility: All sexes
Timeline: 2025 – 2028

Study locations (1)

The first affiliated hospital of medical college of zhejiang university, Hangzhou, Zhejiang, China

Collaborators

Yake Biotechnology Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06769191 on ClinicalTrials.gov

← Back to all trials